When the Heart Is Not to Blame: Managing Lung Disease in Adult Congenital Heart Disease. Prog Cardiovasc Dis 2018;61(3-4):314-319
Date
07/25/2018Pubmed ID
30041022DOI
10.1016/j.pcad.2018.07.019Scopus ID
2-s2.0-85052820919 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
It is well-recognized now that adult survivors with congenital heart disease (CHD) are at risk for non-cardiac co-morbidities and complications that can impact symptoms and clinical outcomes. Lung disease, in particular, is common in this population, but likely an under-recognized and undertreated cause for long-term morbidity. Abnormal lung function contributes to exercise intolerance and is associated with a higher risk for mortality in this population. The exact mechanisms that contribute to abnormal measurements of lung function are not entirely known, and are likely multifactorial and variable depending on the underlying CHD. Nevertheless, lung disease is a potentially modifiable risk factor in this patient population, the management of which may result in improved clinical outcomes. This review summarizes our current understanding of the prevalence, impact and management of lung disease in adults with CHD.
Author List
Ginde S, Earing MGAuthor
Salil Ginde MD, MPH Associate Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultEffect Modifier, Epidemiologic
Heart Defects, Congenital
Humans
Lung Diseases
Patient Care Management
Prevalence
Respiratory Function Tests
Risk Factors
